Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (71-80 of 662) with videos related to

Pageof 67
Sort By:
AIDS (London, England)|November 4, 2010
A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed peopleDavid R Bangsberg, Kathleen Ragland, Alex Monk, et al.
Immunological Reviews|June 19, 2013
Immune activation and HIV persistence: implications for curative approaches to HIV infectionNichole R Klatt, Nicolas Chomont, Daniel C Douek, et al.
Current Opinion in HIV and AIDS|October 28, 2010
Biomarkers in HIV diseaseJens D Lundgren, John Baxter, Steven G Deeks, et al.
Statistics in Medicine|April 24, 2007
Individualized treatment rules: generating candidate clinical trialsMaya L Petersen, Steven G Deeks, Mark J van der Laan
Frontiers in Immunology|April 17, 2020
Editorial: HIV and Cancer Immunotherapy: Similar Challenges and Converging ApproachesMirko Paiardini, Kavita Dhodapkar, Justin Harper, et al.
Blood|May 16, 2002
Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individualsJoAnn C Castelli, Steven G Deeks, Stephen Shiboski, et al.
Journal of Clinical Microbiology|September 7, 2006
Performance of human immunodeficiency virus type 1 gp41 assays for detecting enfuvirtide (T-20) resistance mutationsMichelle Marcial, Jing Lu, Steven G Deeks, et al.
Cell Stem Cell|February 7, 2012
Hematopoietic-stem-cell-based gene therapy for HIV diseaseHans-Peter Kiem, Keith R Jerome, Steven G Deeks, et al.
The Journal of Infectious Diseases|November 17, 2006
Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failureSerena Spudich, Nicole Lollo, Teri Liegler, et al.
The New England Journal of Medicine|September 28, 2012
Case records of the Massachusetts General Hospital. Case 30-2012. A 54-year-old woman with HIV infection, dyspnea, and chest painSteven G Deeks, Rajesh T Gandhi, Claudia U Chae, et al.
Pageof 67

Showing results (71-80 of 662) with videos related to

Sort By:
Pageof 67
AIDS (London, England)|November 4, 2010
A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed peopleDavid R Bangsberg, Kathleen Ragland, Alex Monk, et al.
Immunological Reviews|June 19, 2013
Immune activation and HIV persistence: implications for curative approaches to HIV infectionNichole R Klatt, Nicolas Chomont, Daniel C Douek, et al.
Current Opinion in HIV and AIDS|October 28, 2010
Biomarkers in HIV diseaseJens D Lundgren, John Baxter, Steven G Deeks, et al.
Statistics in Medicine|April 24, 2007
Individualized treatment rules: generating candidate clinical trialsMaya L Petersen, Steven G Deeks, Mark J van der Laan
Frontiers in Immunology|April 17, 2020
Editorial: HIV and Cancer Immunotherapy: Similar Challenges and Converging ApproachesMirko Paiardini, Kavita Dhodapkar, Justin Harper, et al.
Blood|May 16, 2002
Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individualsJoAnn C Castelli, Steven G Deeks, Stephen Shiboski, et al.
Journal of Clinical Microbiology|September 7, 2006
Performance of human immunodeficiency virus type 1 gp41 assays for detecting enfuvirtide (T-20) resistance mutationsMichelle Marcial, Jing Lu, Steven G Deeks, et al.
Cell Stem Cell|February 7, 2012
Hematopoietic-stem-cell-based gene therapy for HIV diseaseHans-Peter Kiem, Keith R Jerome, Steven G Deeks, et al.
The Journal of Infectious Diseases|November 17, 2006
Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failureSerena Spudich, Nicole Lollo, Teri Liegler, et al.
The New England Journal of Medicine|September 28, 2012
Case records of the Massachusetts General Hospital. Case 30-2012. A 54-year-old woman with HIV infection, dyspnea, and chest painSteven G Deeks, Rajesh T Gandhi, Claudia U Chae, et al.
Pageof 67